Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow BIOMERICA INC

Get SEC filing alerts via email and in your feed for BIOMERICA INC

BMRA

BIOMERICA INC

About BIOMERICA INC

Biomerica, Inc. is a global biomedical technology company specializing in the development, manufacturing, and marketing of advanced diagnostic and therapeutic products. Its core offerings include rapid diagnostic test kits for detecting diseases, food intolerances, and medical conditions using blood, urine, nasal, or fecal samples. Serving clinical laboratories and point-of-care markets worldwide, Biomerica leverages patented technologies like inFoods® to provide accurate, easy-to-use tests that support early diagnosis and personalized treatment, enhancing patient care and reducing healthcare costs.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from BIOMERICA INC

1
1
BIOMERICA INC Biomerica Reports Decline in Sales and Increased Losses for Three and Nine Months Ended February 28, 2026

Via official filing (AI summary) | about 2 months ago | 0 comments

2
1
BIOMERICA INC Biomerica Reports Decline in Revenue and Gross Profit for Three and Six Months Ended November 30, 2025

Via official filing (AI summary) | 5 months ago | 0 comments

3
1
BIOMERICA INC Biomerica Reports 24% Revenue Decline but Achieves Net Income Turnaround in Latest Quarter

Via official filing (AI summary) | 8 months ago | 0 comments

4
1
BIOMERICA INC Biomerica Reports $5.31 Million in Net Sales for Fiscal Year Ending May 31, 2025

Via official filing (AI summary) | 9 months ago | 0 comments

5
1
BIOMERICA INC Biomerica Reports 10% Revenue Growth in Third Quarter, Faces Liquidity Challenges

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
BIOMERICA INC Biomerica Reports Modest Sales Growth Amid Continued Operational Losses

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
BIOMERICA INC Biomerica Reports Modest Sales Growth, Continued Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments